Fig. 1From: The speed of adoption of new drugs and prescription volume after the amendments in reimbursement coverage: the case of non-vitamin K antagonist oral anticoagulants in South KoreaThe regulatory approval and reimbursement process of NOACs in the South Korean marketBack to article page